An OTC drug used for allergy treatment could potentially reverse damages done by Multiple Sclerosis

Scientists from UC San Francisco have found that an Over The Counter (OTC) allergy drug could potentially reverse damages done by Multiple Sclerosis (MS) and improve the ability of patients to have more capable bodily functions. MS is a chronic condition which can lead to varying degrees of loss of bodily functions and you can…

Grant awarded to a potentially novel Multiple Sclerosis drug

A particular drug, known as TGR-1202 (umbralisib), has been awarded a grant to support its development from the National Multiple Sclerosis Society. If you are wondering what exactly is MS and why does it affect a person's way of life, you can head over here to find out more about this condition. Grant awarded to a…

Gene immunotherapy could potentially stop and even reverse the development of Multiple Sclerosis

Before I get everyone's hopes up high, just wanted to say that the research is very preliminary, and have not gone on to live human trials. A new research has shown significant results in potentially stopping and reversing the development of Multiple Sclerosis. We first saw this news on GEN. Currently, the research is only…

Deficiency in Vitamin D can lead to increased risk of Multiple Sclerosis

Too much sun is not good for your skin, and can cause skin cancer. A deficiency in sunlight however, might not be good as you will face increased risk of Multiple Sclerosis, according to a new research published by Kassandra Munger, from the US Harvard TH Chan School of Public Health. MS is a serious disease…

Bacteria in intestines might lead to Multiple Sclerosis

There are trillions of bacteria which reside in our intestines, and they are known on a whole as gut microbiome. On a recent report at Science AAAS, they talked about two new studies which might show that gut microbiome could lead to Multiple Sclerosis. Multiple Sclerosis is a condition which turns the body against itself, attacking myelin, the protective nerve fibers…